Data monitoring committees for clinical trials and the role of the statistician

Join us while we discuss these questions with David and learn more about the following points:

• How did David get to this position as a biostatistician at a CRO?
• How is it made sure that information from the DMC stays within the DMC?
• What is David's most challenging and most exciting experience he had while working in a DMC setting?
• When working on open-label trials, it is sometimes requested to “artificially” blind the date but have a DMC review the unblinded data. Has he come across these settings as well, and what’s the challenge he sees here?

References:

https://www.linkedin.com/in/dmcdavid/

https://www.cytel.com/blog/0-key-qualifications-for-independent-statisticians-reporting-to-the-dmc

Listen to this episode and share it with your friends and colleagues!